NSAIDs Stent Study

Summary

NSAIDs Stent Study is a clinical trial^[1].

Key Facts

• NSAIDs Stent Study is in the country of United States^[2].
• NSAIDs Stent Study's instance of is recorded as clinical trial^[3].
• NSAIDs Stent Study's start time is recorded as +2018-07-31T00:00:00Z^[4].
• NSAIDs Stent Study's end time is recorded as +2020-10-31T00:00:00Z^[5].
• NSAIDs Stent Study's sponsor is recorded as Washington University School of Medicine^[6].
• NSAIDs Stent Study's main subject is recorded as nephrolithiasis^[7].
• NSAIDs Stent Study's number of participants is recorded as {'unit': '1', 'amount': '+36'}^[8].
• NSAIDs Stent Study's title is recorded as A Prospective, Randomized, Pilot Study of Preoperative Anti-Inflammatory Therapy for Ureteral Stent Symptoms^[9].
• NSAIDs Stent Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• NSAIDs Stent Study's ClinicalTrials.gov ID is recorded as NCT03638999^[11].
• NSAIDs Stent Study's research intervention is recorded as ketorolac^[12].
• NSAIDs Stent Study's research intervention is recorded as ketorolac tromethamine^[13].
• NSAIDs Stent Study's clinical trial phase is recorded as phase I clinical trial^[14].
• NSAIDs Stent Study's research site is recorded as Washington University in St. Louis^[15].
• NSAIDs Stent Study's research subject recruitment status is recorded as recruiting^[16].
• NSAIDs Stent Study's study type is recorded as interventional study^[17].